Biotech Course Correction With Treehill Partners' Ali Pashazadeh

Business Of Biotech

We love to hear from our listeners. Send us a message.

It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. Yes, it's a bit of a departure from our normal routine of biotech founders occupying the guest chair. But, Pashazadeh's no-holds-barred reflections on and analysis of biotech breaking points, drawn from more than 2 decades of troubleshooting broken bipharmaceutical businesses and correcting courses, makes for some great programming. Whether you're a biotech builder in the throes of disruption, or feeling lucky that you've been threading scientific, clinical, capital, and regulatory needles all along, this episode offers a ton of insight from the unwritten textbooks on the business of biotech.

Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.

Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [e-mail]
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/

Chapter

1. Biotech Course Correction With Treehill Partners' Ali Pashazadeh (00:00:00)

2. Ali Ashazadeh (00:00:04)

3. Medical Doctor Turned Investment Banker (00:14:19)

4. Improving Drug Development Decision-Making (00:26:02)

5. Optimizing Drug Development Decision-Making (00:35:38)

6. Navigating External Influences in Biotech (00:46:01)

7. Navigating Emotional Challenges in Biotech (01:01:07)

8. The Importance of Clinical Trial Disclosure (01:10:35)